State General Laboratory Annual Report 2019

10 State General laboratory Annual Report 2019 The activities of the SGL, a non-conflict of interest organisation, governed by the principles of scientific excel- lence, independence, integrity, accountability and transparency, ensure compliance with the Public Service Law, as well as the fulfillment of citizens’ expectations. Scientific Excellence Intependence Accountability Integrity Transparency Core Principles of the State General Laboratory (SGL) REPUBLIC OF CYPRUS Under the support and configuration of National Policy, within the framework of its responsibilities, the SGL’s staff serves on many National Council Boards (Food, Pharmaceuticals, Cosmetics, Plant Protection Products and Biocides, Veterinary Medicines, Chemicals, Tenders of the Ministry of Health, Chemists Registration) as well as the Cyprus National Addictions Authority, the Food Safety Council, and also in National Committees (e.g. Research and Innovation Coordinators, Environment and Children’s Health, School Canteens, Natural Mineral Water, Environmental Impact, Veterinary Drugs Register, Reduction of Drugs Supply & Drugs Legislation, National Center of Information on Narcotics, ECOLABEL, UN-Children Rights on Health). It is also, among others, at European / international level : the National Representative in the Advisory Forum of the European Food Safety Authority (EFSA) and the National Focal Point of EFSA, the National representa- tive in the Governing Board of the European Joint Research Programme on "Human Biomonitoring for Europe (HBM4EU)" (2017-2021) and the National representative (for Health sector) on "Environment and Health Task Force" of the World Health Organization (WHO)-Europe. Through this active involvement, the SGL contributes to the revision, modernisation and harmonisation of legis- lation, and the formulation of policies / strategies related to its competences, not only at a national but also at European level. Its constant contribution to the revision of food / water / consumer’s products legislation and the legislation on Drugs and Psychotropic Substances for the integration of new synthetic drugs, has been significant.